Accell highly favors international collaborations and is always eager to establish new promising foreign acquaintances. Hence, on August 7, 2018, Accell’s team had the honor to meet a delegation from The Wuhan National Bio-industry Base and welcome it at our Clinical Operations Headquarters in Saint Petersburg, Russia. The Wuhan National Bio-industry Base, also known as the Biolake, is China’s second largest state-level biotech industrial base located in Wuhan East Lake High-tech Development Zone.

About Biolake & the meeting

Construction of the Biolake started in 2007 after approval by the National Development and Reform Commission. Currently, it is a 12 sq.km property consisting of 6 major parks for biology innovation, biomedicine, biofarming, medical devices, medical health, and bioenergy. A bio-manufacturing park is a next step that will render Biolake a thorough R&D, incubation, production, logistics, administration, and residential complex.

Natalia Nayanova and Svetlana Kazanskaya, Accell’s Director of Clinical Operations and Director of Business Development, respectively, had a productive meeting with the Biolake’s delegation outlining common points of interest. It is obvious that China and Russia can benefit greatly by mutual collaboration and establish strong partnerships in R&D sector is no exception. Biolake’s representatives expressed a high level of interest towards collaboration with Accell given its extensive experience in oncology and prominent connections with key opinion leaders and sites in Eastern Europe and Russia. As a result of a meeting, we received a hearty invitation to pay a visit to the Wuhan National Bio-industry Base and attend some of the best and fruitful conferences in China. Thus, it seems Accell is getting on a verge of Asian expansion, and we very much look forward to doing it as soon as possible.